tiprankstipranks
Cardinal Health (DE:CLH)
FRANKFURT:CLH
Germany Market
Want to see DE:CLH full AI Analyst Report?

Cardinal Health (CLH) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

CLH Analyst Ratings

Strong Buy
12Ratings
Strong Buy
10 Buy
2 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Cardinal
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CLH Stock 12 Month Forecast

Average Price Target

€210.01
▲(16.48% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Cardinal Health in the last 3 months. The average price target is €210.01 with a high forecast of €220.26 and a low forecast of €183.55. The average price target represents a 16.48% change from the last price of €180.30.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"120":"€120","221":"€221","145.25":"€145.3","170.5":"€170.5","195.75":"€195.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":220.25547978,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€220.26</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":210.01103886,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€210.01</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":183.54623315,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€183.55</span>\n  </div></div>","useHTML":true}}],"tickPositions":[120,145.25,170.5,195.75,221],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,173.25,176.86580613692308,180.48161227384617,184.09741841076922,187.7132245476923,191.3290306846154,194.94483682153847,198.56064295846153,202.1764490953846,205.7922552323077,209.40806136923078,213.02386750615386,216.63967364307692,{"y":220.25547978,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,173.25,176.07777222,178.90554444,181.73331666,184.56108888,187.3888611,190.21663332,193.04440554,195.87217776,198.69994998,201.5277222,204.35549442,207.18326664,{"y":210.01103886,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,173.25,174.0420179346154,174.83403586923077,175.62605380384616,176.41807173846155,177.21008967307694,178.00210760769232,178.79412554230768,179.58614347692307,180.37816141153846,181.17017934615384,181.96219728076923,182.75421521538462,{"y":183.54623315,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":121.074,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":134.125,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":140.337,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":132.205,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":125.956,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.798,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.447,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":181.055,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.587,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":177.414,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":197.415,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":181.6,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":173.25,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€220.26Average Price Target€210.01Lowest Price Target€183.55
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on DE:CLH
Bank of America Securities
Bank of America Securities
€204.89
Buy
13.64%
Upside
Reiterated
05/13/26
Analysts Conflicted on These Healthcare Names: Cardinal Health (NYSE: CAH), Baxter International (NYSE: BAX) and Cigna (NYSE: CI)
Morgan Stanley Analyst forecast on DE:CLH
Morgan Stanley
Morgan Stanley
€217.69
Buy
20.74%
Upside
Reiterated
05/05/26
Cardinal Health (CAH) Gets a Buy from Morgan Stanley
Argus Research Analyst forecast on DE:CLH
Argus Research
Argus Research
€211.72
Buy
17.43%
Upside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH) and Dexcom (NASDAQ: DXCM)
J.P. Morgan Analyst forecast on DE:CLH
J.P. Morgan
J.P. Morgan
€207.45€183.55
Hold
1.80%
Upside
Assigned
05/04/26
Cardinal Health price target lowered to $215 from $243 at JPMorganCardinal Health price target lowered to $215 from $243 at JPMorgan
Robert W. Baird Analyst forecast on DE:CLH
Robert W. Baird
Robert W. Baird
€219.4€211.72
Buy
17.43%
Upside
Reiterated
05/01/26
Cardinal Health price target lowered to $248 from $257 at BairdCardinal Health price target lowered to $248 from $257 at Baird
TD Cowen
€214.28€217.69
Buy
20.74%
Upside
Assigned
05/01/26
Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and Cardinal Health (NYSE: CAH)
Citi
€212.57€209.16
Buy
16.01%
Upside
Assigned
05/01/26
Cardinal Health price target lowered to $245 from $249 at CitiCardinal Health price target lowered to $245 from $249 at Citi
Evercore ISI
€204.89
Buy
13.64%
Upside
Reiterated
05/01/26
Evercore ISI Remains a Buy on Cardinal Health (CAH)
Barclays
€220.26
Buy
22.16%
Upside
Reiterated
04/30/26
Barclays Keeps Their Buy Rating on Cardinal Health (CAH)
William Blair Analyst forecast on DE:CLH
William Blair
William Blair
Buy
Initiated
04/28/26
Cardinal Health Earns Buy Rating on High-Margin Growth Segments and Double-Digit EPS Outlook
Wells Fargo Analyst forecast on DE:CLH
Wells Fargo
Wells Fargo
€218.55
Buy
21.21%
Upside
Assigned
04/13/26
Wells Fargo Gives a Buy Rating to Cardinal Health (CAH)
Deutsche Bank  Analyst forecast on DE:CLH
Deutsche Bank
Deutsche Bank
Hold
Reiterated
02/20/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Mizuho Securities Analyst forecast on DE:CLH
Mizuho Securities
Mizuho Securities
€200.62
Buy
11.27%
Upside
Reiterated
02/10/26
Mizuho Securities Keeps Their Buy Rating on Cardinal Health (CAH)
UBS
€213.43€221.96
Buy
23.11%
Upside
Reiterated
02/06/26
Cardinal Health price target raised to $260 from $250 at UBSCardinal Health price target raised to $260 from $250 at UBS
Jefferies
€187.81€230.5
Buy
27.84%
Upside
Reiterated
01/22/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Agios Pharma (NASDAQ: AGIO) and Henry Schein (NASDAQ: HSIC)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on DE:CLH
Bank of America Securities
Bank of America Securities
€204.89
Buy
13.64%
Upside
Reiterated
05/13/26
Analysts Conflicted on These Healthcare Names: Cardinal Health (NYSE: CAH), Baxter International (NYSE: BAX) and Cigna (NYSE: CI)
Morgan Stanley Analyst forecast on DE:CLH
Morgan Stanley
Morgan Stanley
€217.69
Buy
20.74%
Upside
Reiterated
05/05/26
Cardinal Health (CAH) Gets a Buy from Morgan Stanley
Argus Research Analyst forecast on DE:CLH
Argus Research
Argus Research
€211.72
Buy
17.43%
Upside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH) and Dexcom (NASDAQ: DXCM)
J.P. Morgan Analyst forecast on DE:CLH
J.P. Morgan
J.P. Morgan
€207.45€183.55
Hold
1.80%
Upside
Assigned
05/04/26
Cardinal Health price target lowered to $215 from $243 at JPMorganCardinal Health price target lowered to $215 from $243 at JPMorgan
Robert W. Baird Analyst forecast on DE:CLH
Robert W. Baird
Robert W. Baird
€219.4€211.72
Buy
17.43%
Upside
Reiterated
05/01/26
Cardinal Health price target lowered to $248 from $257 at BairdCardinal Health price target lowered to $248 from $257 at Baird
TD Cowen
€214.28€217.69
Buy
20.74%
Upside
Assigned
05/01/26
Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and Cardinal Health (NYSE: CAH)
Citi
€212.57€209.16
Buy
16.01%
Upside
Assigned
05/01/26
Cardinal Health price target lowered to $245 from $249 at CitiCardinal Health price target lowered to $245 from $249 at Citi
Evercore ISI
€204.89
Buy
13.64%
Upside
Reiterated
05/01/26
Evercore ISI Remains a Buy on Cardinal Health (CAH)
Barclays
€220.26
Buy
22.16%
Upside
Reiterated
04/30/26
Barclays Keeps Their Buy Rating on Cardinal Health (CAH)
William Blair Analyst forecast on DE:CLH
William Blair
William Blair
Buy
Initiated
04/28/26
Cardinal Health Earns Buy Rating on High-Margin Growth Segments and Double-Digit EPS Outlook
Wells Fargo Analyst forecast on DE:CLH
Wells Fargo
Wells Fargo
€218.55
Buy
21.21%
Upside
Assigned
04/13/26
Wells Fargo Gives a Buy Rating to Cardinal Health (CAH)
Deutsche Bank  Analyst forecast on DE:CLH
Deutsche Bank
Deutsche Bank
Hold
Reiterated
02/20/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Mizuho Securities Analyst forecast on DE:CLH
Mizuho Securities
Mizuho Securities
€200.62
Buy
11.27%
Upside
Reiterated
02/10/26
Mizuho Securities Keeps Their Buy Rating on Cardinal Health (CAH)
UBS
€213.43€221.96
Buy
23.11%
Upside
Reiterated
02/06/26
Cardinal Health price target raised to $260 from $250 at UBSCardinal Health price target raised to $260 from $250 at UBS
Jefferies
€187.81€230.5
Buy
27.84%
Upside
Reiterated
01/22/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Agios Pharma (NASDAQ: AGIO) and Henry Schein (NASDAQ: HSIC)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cardinal Health

3 Months
xxx
Success Rate
13/18 ratings generated profit
72%
Average Return
+4.44%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 72.22% of your transactions generating a profit, with an average return of +4.44% per trade.
1 Year
Success Rate
16/18 ratings generated profit
89%
Average Return
+26.52%
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +26.52% per trade.
2 Years
xxx
Success Rate
16/18 ratings generated profit
89%
Average Return
+61.07%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 88.89% of your transactions generating a profit, with an average return of +61.07% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CLH Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
17
24
23
17
13
Hold
1
2
2
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
26
25
19
14
In the current month, CLH has received 13 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CLH average Analyst price target in the past 3 months is 210.01.
Each month's total comprises the sum of three months' worth of ratings.

CLH Financial Forecast

CLH Earnings Forecast

Next quarter’s earnings estimate for CLH is €2.05 with a range of €1.96 to €2.09. The previous quarter’s EPS was €2.70. CLH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.
Next quarter’s earnings estimate for CLH is €2.05 with a range of €1.96 to €2.09. The previous quarter’s EPS was €2.70. CLH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.

CLH Sales Forecast

Next quarter’s sales forecast for CLH is €55.63B with a range of €54.60B to €57.24B. The previous quarter’s sales results were €51.99B. CLH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.
Next quarter’s sales forecast for CLH is €55.63B with a range of €54.60B to €57.24B. The previous quarter’s sales results were €51.99B. CLH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.

CLH Stock Forecast FAQ

What is DE:CLH’s average 12-month price target, according to analysts?
Based on analyst ratings, Cardinal Health’s 12-month average price target is 210.01.
    What is DE:CLH’s upside potential, based on the analysts’ average price target?
    Cardinal Health has 16.48% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Cardinal Health a Buy, Sell or Hold?
          Cardinal Health has a consensus rating of Strong Buy, which is based on 10 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Cardinal Health’s share price target?
            The average share price target for Cardinal Health is 210.01. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €220.26 ,and the lowest forecast is €183.55. The average share price target represents 16.48% Increase from the current price of €180.3.
              What do analysts say about Cardinal Health?
              Cardinal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of Cardinal Health?
                To buy shares of DE:CLH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.